Oncology Views & Analysis

Views & Analysis

Patients

ASCO 26: Three cancer survivors share lessons for the field

In honour of National Cancer Survivors' Day, we recount three patient testimonies and calls to action from ASCO Voices at ASCO 2026.

Oncology

ASCO 2026: Chinese firms take a front seat in oncology, with...

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Oncology

Female cancer survivor and her grown daughter

Cancer patients don’t care where the breakthrough happened. ...

National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.

Oncology

ASCO 26: Precision medicine takes a village, with Carolyn So...

In this interview with pharmaphorum, J&J's Henar Hevia and Carolyn Sousa, share their some of the company's data wins at the show and talk trends.

Patients

ASCO 26: War, disasters, policy compound cancer care challen...

A Friday ASCO session highlighted the challenges faced by cancer patients in situations of geopolitical crisis, as presenters called for more support.

Oncology

ASCO 26: Three strong Pfizer phase 3s, with Johanna Bendell

Pharmaphorum caught up with Johanna Bendell, Pfizer’s chief development officer for oncology, to learn about what the company is bringing to ASCO.

ASCO 26: Three cancer survivors share lessons for the field

ASCO 2026: Chinese firms take a front seat in oncology, with...

Cancer patients don’t care where the breakthrough happened. ...

ASCO 26: Precision medicine takes a village, with Carolyn So...

ASCO 26: War, disasters, policy compound cancer care challen...

ASCO 26: Three strong Pfizer phase 3s, with Johanna Bendell

Sleep apnoea drug firm Apnimed files for IPO

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks